Home / Healthcare / Introduction of GMP and GDP Standards in the Pharmaceutical Market Begins

Introduction of GMP and GDP Standards in the Pharmaceutical Market Begins

 Pharmaceutical companies will have to maintain European standards within the next few years. The Ministry of Health begins to implement GMP (Good Production Practice) and GDP (Good Distribution Practice) Standard to ensure quality of medicines produced and imported in the country.

Additionally, the inspection of pharmaceutical enterprises and distribution networks will be mandatory starting from January 1, 2022.

The Ministry believes that the introduction of GMP / GDP standards ensures the quality of pharmaceutical products in circulation and export of medicines produced in Georgia. It will also facilitate the strengthening of the pharmaceutical sector and the economic development of the country.

The World Health Organization (WHO) recommends the introduction of such standards, a strategy consisting of several stages. Among them is the establishment of the GMP National Inspectorate.

In order to create an inspectorate, the Ministry of Health will select candidates for inspectors. From the contestants the agency will select candidates who will be specially trained abroad. Candidates who successfully pass preparation courses will be awarded with appropriate certificates and they will conduct inspection of pharmaceutical enterprises and distribution networks. Inspection will be voluntary before it becomes a mandatory norm.